The Biologic and Medical Imaging Reagents Market is expected to be around US$ 37.60 Billion by 2028 at a CAGR of 10.6% in the given forecast period.
New developments in biomarker technology in medical diagnostics will mainly drive the growth of Biologic and Medical Imaging Reagents Market.
Quick improvements over various innovation fields guarantee to change the biological imaging sector by empowering novel imaging reagents and unique market opportunities.
Biologic and Medical imaging is the strategy and technique of making visual depictions of within a body for clinical examination and restorative intervention and visual depiction of the limit of a couple of organs or tissues. Restorative imaging hopes to reveal inward structures concealed by the skin and bones, and furthermore to break down and treat the infirmity. Therapeutic imaging also develops a database of regular life system and physiology to make it possible to recognize variations from the standard.
The global Biologic and Medical Imaging Reagents market is segregated on the basis of Technology as Chelating Molecules, Microbubbles, Fluorescent Proteins, Nanoparticles, Small Chemicals, Probes, and Radiotracers. Based on Application the global Biologic and Medical Imaging Reagents market is segmented in Radioactive Imaging, Contrast Imaging, and Optical Imaging. Based on Modality the global Biologic and Medical Imaging Reagents market is segmented in Nuclear, MRI, Ultrasound, Optical, and X-ray/CT.
The global Biologic and Medical Imaging Reagents market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biologic and Medical Imaging Reagents market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Erigal Ltd., Daiichi Sankyo Co. Ltd., Cardinal Health, Bayer Healthcare Ag, American Dye Source Inc., Fuji Pharma Co. Ltd., Guerbet, Invisage Inc., Johnson & Johnson, Life Technologies Inc., and others are among the major players in the global Biologic and Medical Imaging Reagents market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biologic and Medical Imaging Reagents Market has been segmented as below:
Biologic and Medical Imaging Reagents Market, By Technology
Biologic and Medical Imaging Reagents Market, By Application
Biologic and Medical Imaging Reagents Market, By Modality
Biologic and Medical Imaging Reagents Market, By Region
Biologic and Medical Imaging Reagents Market, By Company
The report covers:
Report Scope:
The global Biologic and Medical Imaging Reagents market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biologic and Medical Imaging Reagents market share. Major industry players with significant revenue share include Erigal Ltd., Daiichi Sankyo Co. Ltd., Cardinal Health, Bayer Healthcare Ag, American Dye Source Inc., Fuji Pharma Co. Ltd., Guerbet, Invisage Inc., Johnson & Johnson, Life Technologies Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Biologic and Medical Imaging Reagents Market, By Technology
5.1 Introduction
5.2 Chelating Molecules
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Microbubbles
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Fluorescent Proteins
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Nanoparticles
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Small Chemicals
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Probes
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Radiotracers
5.8.1 Market Overview
5.8.2 Market Size and Forecast
6. Biologic and Medical Imaging Reagents Market, By Application
6.1 Introduction
6.2 Radioactive Imaging
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Contrast Imaging
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Optical Imaging
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Biologic and Medical Imaging Reagents Market, By Modality
7.1 Introduction
7.2 Nuclear
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 MRI
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Ultrasound
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Optical
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 X-ray/CT
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Biologic and Medical Imaging Reagents Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Biologic and Medical Imaging Reagents, By Technology
8.2.2 North America Biologic and Medical Imaging Reagents, By Application
8.2.3 North America Biologic and Medical Imaging Reagents, By Modality
8.3 Europe
8.3.1 Europe Biologic and Medical Imaging Reagents, By Technology
8.3.2 Europe Biologic and Medical Imaging Reagents, By Application
8.3.3 Europe Biologic and Medical Imaging Reagents, By Modality
8.4 Asia-Pacific
8.4.1 Asia-Pacific Biologic and Medical Imaging Reagents, By Technology
8.4.2 Asia-Pacific Biologic and Medical Imaging Reagents, By Application
8.4.3 Asia-Pacific Biologic and Medical Imaging Reagents, By Modality
8.5 Rest of the World
8.5.1 Rest of the World Biologic and Medical Imaging Reagents, By Technology
8.5.2 Rest of the World Biologic and Medical Imaging Reagents, By Application
8.5.3 Rest of the World Biologic and Medical Imaging Reagents, By Modality
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Erigal Ltd.
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Daiichi Sankyo Co. Ltd.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Cardinal Health
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Bayer Healthcare Ag
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 American Dye Source Inc.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Fuji Pharma Co. Ltd.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Guerbet
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Invisage Inc.
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Johnson & Johnson
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Life Technologies Inc.
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Biologic and Medical Imaging Reagents Market has been segmented as below:
Biologic and Medical Imaging Reagents Market, By Technology
Biologic and Medical Imaging Reagents Market, By Application
Biologic and Medical Imaging Reagents Market, By Modality
Biologic and Medical Imaging Reagents Market, By Region
Biologic and Medical Imaging Reagents Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
